NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 5, 2025 — HeartBeam (NASDAQ: BEAT) appoints CEO Robert Eno to Board of Directors for the launch of 3D ECG technology pending FDA clearance. Learn how their innovative approach could transform cardiac care outside medical facilities.
May 5, 2025 — Quantum BioPharma files amended complaint against CIBC World Markets and RBC Dominion Securities in U.S. District Court for alleged securities violations, seeking damages exceeding $700 million. Learn more about the innovative biotech solutions and strategic investments of Quantum BioPharma.
May 5, 2025 — NanoViricides, Inc., a clinical-stage company developing antivirals, to join D. Boral Capital Global Conference. Learn about lead drug candidate NV-387 for COVID-19 and respiratory infections.
May 5, 2025 — Soligenix, a biopharmaceutical company, demonstrates the potential of HyBryte in treating cutaneous T-cell lymphoma (CTCL) with promising interim results. Learn about the innovative therapy's impact on addressing the unmet medical needs of CTCL patients and its potential to revolutionize treatment options.
May 5, 2025 — Pacylex Pharmaceuticals CEO to present on NMT inhibitors as ADC payloads at the 2nd Annual ADC Payload Summit in Boston. Learn about the potential breakthrough in cancer treatment with zelenirstat in Phase 1 trials.
May 3, 2025 — The Health & Well-Being Journal™ launches on Kickstarter, offering a science-backed daily planner for optimizing health. Created by Keith and Nina Herman, this tool provides practical strategies for sustainable health habits without guilt.
May 2, 2025 — Patients are ditching Medicare Advantage plans as hospitals cut ties with providers, impacting healthcare choices. Astiva Health updates and communication solutions for biotech and life sciences companies.
May 2, 2025 — Aditxt announces progress on ADI-100 with Chief Innovation Officer and Co-CEO participating in Weekly Update. Learn more about the latest developments in health innovation and immune-modulating therapies.
May 2, 2025 — A new analysis published in Circulation: Heart Failure reveals how hospitals participating in the American Heart Association’s initiative significantly improved adherence to guideline-directed medical therapy for heart failure patients with reduced ejection fraction. The study highlights the impact of the IMPLEMENT-HF™ program in increasing the use of life-saving medications and addressing social needs in patient care, emphasizing the importance of collaborative healthcare efforts for better patient outcomes.
May 2, 2025 — Discover Kentucky's healthcare excellence with RCR|HUB's special Derby Edition of RCM Connections Magazine. Gain insights into RCM performance and the dedication of healthcare leaders during the Kentucky Derby season.
May 2, 2025 — Cherished Mom announces the 5th Annual Pregnancy & Postpartum Psychosis Awareness Day to raise awareness about this severe perinatal disorder. Learn more about the campaign and how it aims to provide support to mothers and families across the country.
May 2, 2025 — BalanceRX introduces telehealth services for active adults 45 and older, providing personalized care strategies to support energy, stamina, and athletic performance. Learn how BalanceRX empowers individuals to live vibrantly, perform their best, and embrace life's adventures at any age.
May 1, 2025 — GeoVax announces updates on COVID-19 vaccine program, GEO-MVA clinical evaluation, and Gedeptin® Phase 2 trial for head and neck cancer treatment. Learn about the company's innovative immunotherapies and vaccines addressing critical unmet needs in oncology and infectious diseases.
May 1, 2025 — HealthLynked (HLYK) introduces new appointment booking enhancements to improve patient access to care. CEO Dr. Michael Dent highlights in-network booking, concierge requests, and provider reviews, aiming to strengthen patient experiences and drive better health outcomes.
May 1, 2025 — TransCode Therapeutics reports positive Phase 1a trial results for TTX-MC138, an RNA-based therapeutic targeting microRNA-10b in metastatic cancer. The company's focus on RNA therapeutics for treating metastatic disease could revolutionize cancer treatment options. Learn more about the latest developments in biotech and life sciences sectors with BioMedWire.
May 1, 2025 — Santa Cruz implements a sugary drink tax after a seven-year battle against the soda industry. This victory showcases the importance of public health policies and grassroots advocacy in promoting healthier communities.
May 1, 2025 — Scinai Immunotherapeutics to host webinar discussing PC111 monoclonal antibody for rare skin conditions. Learn about collaboration with Pincell and development plans. Impactful insights for patients and investors.
May 1, 2025 — Amsterdam University Medical Center researchers pioneer a new test for rapid bacterial meningitis diagnosis, showcasing progress in infectious diseases research. This breakthrough could revolutionize bacterial infection diagnosis and treatment worldwide.
May 1, 2025 — American Stroke Association, Stroke Hero Awards, stroke survivors, stroke awareness, stroke community, American Stroke Month, stroke education
May 1, 2025 — Soligenix advances rare disease treatment with HyBryte(TM) therapy for CTCL, showing promising results in a study. Learn more about the global market growth and the impact on patients.